Boxer Capital’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-500,000
| Closed | -$112M | – | 67 |
|
|
2024
Q3 | $112M | Hold |
500,000
| – | – | 5.51% | 4 |
|
|
2024
Q2 | $71.3M | Hold |
500,000
| – | – | 3.76% | 9 |
|
|
2024
Q1 | $78.2M | Hold |
500,000
| – | – | 3.86% | 10 |
|
|
2023
Q4 | $90.2M | Hold |
500,000
| – | – | 4.49% | 6 |
|
|
2023
Q3 | $89.9M | Hold |
500,000
| – | – | 4.79% | 3 |
|
|
2023
Q2 | $89.2M | Hold |
500,000
| – | – | 4.13% | 6 |
|
|
2023
Q1 | $108M | Hold |
500,000
| – | – | 5.29% | 3 |
|
|
2022
Q4 | $110M | Hold |
500,000
| – | – | 5.8% | 2 |
|
|
2022
Q3 | $67.4M | Hold |
500,000
| – | – | 3.79% | 7 |
|
|
2022
Q2 | $80.9M | Hold |
500,000
| – | – | 5.13% | 3 |
|
|
2022
Q1 | $94.3M | Hold |
500,000
| – | – | 4.85% | 4 |
|
|
2021
Q4 | $135M | Sell |
500,000
-264,188
| -35% | -$89.2M | 5.26% | 4 |
|
|
2021
Q3 | $277M | Hold |
764,188
| – | – | 9.69% | 2 |
|
|
2021
Q2 | $262M | Hold |
764,188
| – | – | 9.25% | 2 |
|
|
2021
Q1 | $266M | Sell |
764,188
-350,000
| -31% | -$116M | 9.02% | 2 |
|
|
2020
Q4 | $288M | Hold |
1,114,188
| – | – | 9.25% | 2 |
|
|
2020
Q3 | $319M | Buy |
1,114,188
+189,188
| +20% | +$44.5M | 11.03% | 2 |
|
|
2020
Q2 | $174M | Hold |
925,000
| – | – | 7.66% | 3 |
|
|
2020
Q1 | $114M | Hold |
925,000
| – | – | 7.76% | 3 |
|
|
2019
Q4 | $153M | Hold |
925,000
| – | – | 8.67% | 3 |
|
|
2019
Q3 | $113M | Buy |
925,000
+25,000
| +3% | +$3.32M | 8.21% | 3 |
|
|
2019
Q2 | $112M | Hold |
900,000
| – | – | 9.59% | 3 |
|
|
2019
Q1 | $119M | Hold |
900,000
| – | – | 13.74% | 2 |
|
|
2018
Q4 | $126M | Buy |
900,000
+270,000
| +43% | +$35.8M | 15.6% | 1 |
|
|
2018
Q3 | $108M | Hold |
630,000
| – | – | 12.04% | 2 |
|
|
2018
Q2 | $96.8M | Hold |
630,000
| – | – | 10.97% | 2 |
|
|
2018
Q1 | $106M | Buy |
630,000
+30,000
| +5% | +$4.06M | 11.3% | 2 |
|
|
2017
Q4 | $58.6M | Hold |
600,000
| – | – | 10.72% | 3 |
|
|
2017
Q3 | $62.1M | Hold |
600,000
| – | – | 14.13% | 2 |
|
|
2017
Q2 | $27M | Sell |
600,000
-250,000
| -29% | -$9.85M | 6.42% | 7 |
|
|
2017
Q1 | $31.1M | Hold |
850,000
| – | – | 6.8% | 6 |
|
|
2016
Q4 | $25.8M | Buy |
850,000
+356,370
| +72% | +$11.2M | 9.98% | 4 |
|
|
2016
Q3 | $15.2M | Hold |
493,630
| – | – | 6.82% | 5 |
|
|
2016
Q2 | $14.7M | Buy |
493,630
+76,751
| +18% | +$2.25M | 13.04% | 1 |
|
|
2016
Q1 | $12.2M | Buy |
+416,879
| New | +$11.8M | 11.96% | 3 |
|
Other funds holding ONC
BBA
HA
Boxer Capital's ONC Position: Q4 2024 in Review
Boxer Capital sold out of BeOne Medicines Ltd (ONC) in Q4 2024, closing a stake of 500,000 shares — an estimated $112M sold.
Boxer Capital first reported a position in ONC in Q1 2016 and held it in 35 quarters. The position peaked at $319M in Q3 2020. 228 funds tracked by Wall St. Rank hold ONC as of Q4 2024.
- Boxer Capital reported no remaining BeOne Medicines Ltd position as of Q4 2024 after selling out during the quarter.
- Boxer Capital sold 500,000 BeOne Medicines Ltd shares in Q4 2024, an estimated $112M.
- Boxer Capital first reported a position in BeOne Medicines Ltd in Q1 2016 and held it in 35 quarters.
- Boxer Capital's BeOne Medicines Ltd position peaked at $319M in Q3 2020.
- 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2024.
Based on Boxer Capital's 13F filing for Q4 2024.